Clinical Trial Update: Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing everolimus-eluting bioresorbable scaffolds to everolimus-eluting metallic stents for diffuse long coronary artery disease; study termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting bioresorbable scaffold (everolimus-eluting bioresorbable scaffold)
• Everolimus-eluting metallic stent (everolimus-eluting stent)

Snippet

Sponsor: Duk-Woo Park, MD | Conditions: Percutaneous Transluminal Coronary Angioplasty | Phase 4 | Status: TERMINATED